A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer - Concepedia

Concepedia

Publication | Open Access

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

DOI Full Paper Access

86

Citations

23

References

2015

Year

Seong Hoon Lim, Tae Won Kim, Yuancheng Hong, Seung Woo Han, Kyung‐Ha Lee, Hye Jin Kang, Inwoo Hwang, J Y Lee, Hyo Song Kim, S T Kim,

British Journal of Cancer

Abstract

The addition of 40 mg simvastatin to the XELIRI/FOLFIRI regimens did not improve PFS in patients with previously treated metastatic colorectal cancer nor did it increase toxicity.

References

	Year	Citations

Page 1